59
Views
97
CrossRef citations to date
0
Altmetric
Article

The Tightly Controlled Deubiquitination Activity of the Human SAGA Complex Differentially Modifies Distinct Gene Regulatory Elements

, , , , , , & show all
Pages 3734-3744 | Received 17 Feb 2011, Accepted 30 Jun 2011, Published online: 20 Mar 2023
 

Abstract

The multisubunit SAGA coactivator complex facilitates access of general transcription factors to DNA through histone acetylation mediated by GCN5. USP22 (ubiquitin-specific protease 22) was recently described as a subunit of the human SAGA complex that removes ubiquitin from monoubiquitinated histone H2B and H2A in vitro. Here we demonstrate an allosteric regulation of USP22 through multiple interactions with different domains of other subunits of the SAGA deubiquitination module (ATXN7, ATXN7L3, and ENY2). Downregulation of ATXN7L3 by short hairpin RNA (shRNA) specifically inactivated the SAGA deubiquitination activity, leading to a strong increase of global H2B ubiquitination and a moderate increase of H2A ubiquitination. Thus, SAGA is the major H2Bub deubiquitinase in human cells, and this activity cannot be fully compensated by other deubiquitinases. Here we show that the deubiquitination activity of SAGA is required for full activation of SAGA-dependent inducible genes. Interestingly, the reduction of the SAGA deubiquitination activity and the parallel increase in H2B ubiquitation at inducible target genes before activation do not induce aberrant gene expression. Our data together indicate that different dynamic equilibriums of H2B ubiquitination/deubiquitination are established at different gene regulatory elements and that H2B ubiquitination changes are necessary but not sufficient to trigger parallel activation of gene expression.

View publisher note:
Articles of Significant Interest Selected from This Issue by the Editors

ACKNOWLEDGMENTS

We thank Arnaud Krebs and Anne Helmrich for comments on the manuscript. We also thank Pang-Hung Hsu for mass spectrometry analysis, Christophe Romier and Imre Berger for gifts of materials, and Elisabeth Scheer and Isabelle Kolb-Cheynel for technical help.

J.B. received an FRM fellowship and G.L. was supported by a fellowship from the Ligue contre le cancer and from CSC. This work was supported by grants from the ANR (ANR-09-MNPS-023, ANR-09-PIRI-0031, ANR-10-INTB-1201) to D.D. and by grants from ANR (ANR-09-BLAN-0266), the EU (EUTRACC, LSHG-CT-2007-037445 and EPIDIACAN), and the INCA (2008 Ubican) to L.T.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.